Elasa - Net Worth and Insider Trading
Elasa Net Worth
The estimated net worth of Elasa is at least $20 Million dollars as of 2024-12-15. Elasa is the 2101 Beneficial owner of Clover Biopharmaceuticals Ltd and owns about 73,059,413 shares of Clover Biopharmaceuticals Ltd (HKSE:02197) stock worth over $20 Million. Details can be seen in Elasa's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elasa has not made any transactions after 2021-11-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Elasa
Elasa Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Elasa owns 1 companies in total, including Clover Biopharmaceuticals Ltd (HKSE:02197) .
Click here to see the complete history of Elasa’s form 4 insider trades.
Insider Ownership Summary of Elasa
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02197 | Clover Biopharmaceuticals Ltd | 2021-11-05 | 2101 Beneficial owner |
Elasa Latest Holdings Summary
Elasa currently owns a total of 1 stock. Elasa owns 73,059,413 shares of Clover Biopharmaceuticals Ltd (HKSE:02197) as of November 5, 2021, with a value of $20 Million.
Latest Holdings of Elasa
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02197 | Clover Biopharmaceuticals Ltd | 2021-11-05 | 73,059,413 | 0.27 | 19,726,042 |
Holding Weightings of Elasa
Elasa Form 4 Trading Tracker
According to the SEC Form 4 filings, Elasa has made a total of 1 transactions in Clover Biopharmaceuticals Ltd (HKSE:02197) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Clover Biopharmaceuticals Ltd is the sale of 73,059,413 shares on November 5, 2021, which brought Elasa around $0.
Insider Trading History of Elasa
- 1
Elasa Trading Performance
Elasa Ownership Network
Ownership Network List of Elasa
Ownership Network Relation of Elasa
Elasa Owned Company Details
What does Clover Biopharmaceuticals Ltd do?
Who are the key executives at Clover Biopharmaceuticals Ltd?
Elasa is the 2101 Beneficial owner of Clover Biopharmaceuticals Ltd. Other key executives at Clover Biopharmaceuticals Ltd include 2101 Beneficial owner Liang Peng , 2501 Other Liang Joshua G , and 2201 Interest of corporation controlled by you JPMorgan Chase & Co. .
Clover Biopharmaceuticals Ltd (HKSE:02197) Insider Trades Summary
Over the past 18 months, Elasa made no insider transaction in Clover Biopharmaceuticals Ltd (HKSE:02197). Other recent insider transactions involving Clover Biopharmaceuticals Ltd (HKSE:02197) include a net purchase of 1,519,000 shares made by Liang Joshua G , and a net sale of 6,000 shares made by Liang Peng .
In summary, during the past 3 months, insiders sold 0 shares of Clover Biopharmaceuticals Ltd (HKSE:02197) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000 shares of Clover Biopharmaceuticals Ltd (HKSE:02197) were sold and 1,519,000 shares were bought by its insiders, resulting in a net purchase of 1,513,000 shares.
Clover Biopharmaceuticals Ltd (HKSE:02197)'s detailed insider trading history can be found in Insider Trading Tracker table.
Clover Biopharmaceuticals Ltd Insider Transactions
Elasa Mailing Address
Above is the net worth, insider trading, and ownership report for Elasa. Currently GuruFocus does not have mailing address information for Elasa.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
